The U.S. Food and Drug Administration approved a pre-filled syringe version of GSK's blockbuster shingles vaccine Shingrix, ...

For decades, proponents of psychedelic drugs have come to Washington with a provocative message: Illegal, mind-altering ...

On Monday, the U.S. Department of Health and Human Services (HHS) finalized 10,000 layoffs across federal health agencies, ...

A production issue raised concerns that ink printing on some cups could run when exposed to high temperatures, inspectors ...

The U.S. Food and Drug Administration's reviewers on Wednesday raised efficacy concerns over the use of Otsuka Pharma's drug ...

The U.S. Food and Drug Administration on Monday approved the use of a new blue color additive from the gardenia fruit the ...

By Stephanie Brown HealthDay ReporterTUESDAY, July 15, 2025 (HealthDay News) -- The U.S Food and Drug Administration has ...

MENOPAUSAL THERAPY IN FOCUS — The FDA will hold a panel discussion Thursday on hormone therapy for menopausal women, a pet ...

Note that some links may require registration or subscription. White House officials overrode NIH career staff in deciding which "dangerous gain-of-function research" projects on viruses and pathogens ...

Treatments for bronchiectasis, chronic immune thrombocytopenia, fibromyalgia, Friedreich ataxia, and recurrent respiratory papillomatosis are under review.

FDA reviewers flag "discordant results" in a briefing document published ahead of Friday's advisory committee meeting for the ...

Biohaven’s valuation has dropped from $3.9B to $1.42B, but no revenue and high cash burn still limit its appeal. Read why ...